BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10921762)

  • 1. Equivalent therapeutic ratio of salbutamol given by Turbuhaler and Diskus.
    Arvidsson P; Mellén A; Palmqvist M; Lötvall J
    Respir Med; 2000 Jun; 94(6):574-7. PubMed ID: 10921762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler.
    Mellén A; Arvidsson P; Palmqvist M; Lötvall J
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1663-5. PubMed ID: 10228142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction.
    Löfdahl CG; Andersson L; Bondesson E; Carlsson LG; Friberg K; Hedner J; Hörnblad Y; Jemsby P; Källén A; Ullman A; Werner S; Svedmyr N
    Eur Respir J; 1997 Nov; 10(11):2474-8. PubMed ID: 9426081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the bronchodilatory effect of 50 and 100 microg salbutamol via Turbuhaler and 100 microg salbutamol via pressurized metered dose inhaler in children with stable asthma.
    Razzouk H; dos Santos L; Giudicelli J; Queirós M; de Lurdes Chieira M; Castro A; Ramos C; Lindbladh C
    Int J Pharm; 1999 Apr; 180(2):169-75. PubMed ID: 10370187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salbutamol via Easyhaler is at least as effective as salbutamol via Turbuhaler in the treatment of histamine-induced bronchoconstriction.
    Zetterström O; Lähelmä S; Keski-karhu J; Silvasti M; Ostling-kulling E; Ahonen A
    Respir Med; 2000 Nov; 94(11):1097-102. PubMed ID: 11127498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI.
    Seberová E; Andersson A
    Respir Med; 2000 Jun; 94(6):607-11. PubMed ID: 10921767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
    Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
    Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical equivalence between salbutamol hydrofluoroalkane pMDI and salbutamol Turbuhaler at the same cumulative microgram doses in paediatric patients.
    Gustafsson P; Källman S; Whitehead PJ
    Respir Med; 2002 Nov; 96(11):957-9. PubMed ID: 12418596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI.
    Broeders ME; Molema J; Hop WC; Folgering HT
    Eur J Clin Pharmacol; 2005 Feb; 60(12):837-41. PubMed ID: 15625613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma.
    Nana A; Youngchaiyud P; Maranetra N; Boe J; Löfdahl CG; Selroos O; Ståhl E
    Respir Med; 1998 Feb; 92(2):167-72. PubMed ID: 9616507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma.
    Boonsawat W; Charoenratanakul S; Pothirat C; Sawanyawisuth K; Seearamroongruang T; Bengtsson T; Brander R; Selroos O
    Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction.
    Carlsson LG; Arweström E; Friberg K; Källén A; Lunde H; Löfdahl CG
    Allergy; 1998 Jul; 53(7):712-5. PubMed ID: 9700042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the bronchodilator effect of salbutamol inhaled via Turbuhaler as two consecutive doses or as two divided doses at different time intervals.
    Lindbladh C; Smith P; Jackson L; Begishvilli B; Jamieson A; Holgate ST
    Int J Pharm; 1999 Nov; 190(1):57-62. PubMed ID: 10528097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
    Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism.
    Lavorini F; Geri P; Mariani L; Marmai C; Maluccio NM; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2006 Oct; 62(4):403-11. PubMed ID: 16995861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices.
    Seppälä OR; Aalto E; Annila ; Hakonen T; Lukkari-Lax E; Jouhikainen T; Nieminen MM; Liipp K
    Respir Med; 2001 Dec; 95(12):949-53. PubMed ID: 11778791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol Turbuhaler as reliever medication in patients with acute asthma.
    Rubinfeld AR; Scicchitano R; Hunt A; Thompson PJ; Van Nooten A; Selroos O
    Eur Respir J; 2006 Apr; 27(4):735-41. PubMed ID: 16455838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma.
    Gioulekas D; Papakosta D; Vordoyianni P; Baloti H; Vamvalis C
    Respir Med; 1996 Apr; 90(4):205-9. PubMed ID: 8736653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the inhalation device affect the bronchodilatory dose response curve of salbutamol in asthma and chronic obstructive pulmonary disease patients?
    Broeders ME; Molema J; Hop WC; Vermue NA; Folgering HT
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):449-55. PubMed ID: 12920494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.